Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapies with 3rd generation EGFR tyrosine kinase inhibitors

Therapies with 3rd generation EGFR tyrosine kinase inhibitors

US Patent 11850248 · Granted Dec 26, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Non-linear encoding and decoding for reliable wireless communication2025
Modulation of β-catenin/TCF-activated transcription2009